Phase Ia first-in-man trial of GLN 1062 in healthy young and adult volunteers.
Phase of Trial: Phase I
Latest Information Update: 17 Sep 2014
Price : $35 *
At a glance
- Drugs GLN 1062 (Primary) ; Donepezil; Galantamine
- Indications Alzheimer's disease
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors Neurodyn
- 17 Sep 2014 New trial record
- 09 Sep 2014 Results published in the Media Release.